Abstract:Tendinopathy is a critical clinical problem as it is often asymptomatic at onset and during development, and is only recognized upon rupture of the tendon. It is common among recreational and competitive athletes. The present study sought to examine the molecular mechanism of the progression of tendinopathy by screening out differentially expressed genes (DEGs) and investigating their functions. In addition, the present study aimed to identify the small molecules, which exhibit potential effects, which could be utilized for the treatment of tendinopathy. The gene expression profile of tendinopathy, GSE26051 was downloaded from the Gene Expression Omnibus database, which included 23 control samples and 18 samples of tendinopathy. The DEGs were identified using the Limma package in the R programming language, and gene ontology and pathway enrichment analysis were performed. In addition, the potential regulatory microRNAs and the target sites of the transcription factors were screened out based on the molecular signature database. In addition, the DEGs were mapped to the connectivity map database to identify the potential small molecule drugs. A total of 318 genes were filtered as DEGs between diseased samples and normal control tendons. Additionally, genes, including laminin, α4, platelet‑derived growth factor α, laminin γ1 and Src homology 2 transforming protein 1 may induce tendinopathy through the focal adhesion pathway. Furthermore, the transcription factor, lymphoid enhancer‑binding factor 1 and its target genes, pantothenate kinase 2 and G protein‑coupled receptor kinase 5 were identified. The most significant microRNA, miR‑499, was screened and was found to regulate specific genes, including CUGBP2 and MYB. Additionally, the small molecules, Prestwick‑1082 and viomycin were identified to have the potential to repair disordered metabolic pathways and furthermore to remedy tendinopathy. The results of the present study assessed the mechanism of tendinopathy and screened small molecule drugs as potential treatments for this condition. In addition, the present findings have the potential for use in a clinical setting for the treatment of tendinopathy in the future.

MicroRNA 148A-3P Promotes Thrombospondin-4 Expression and Enhances Angiogenesis During Tendinopathy Development by Inhibiting Krüppel-like Factor 6.

MiR-378a Suppresses Tenogenic Differentiation and Tendon Repair by Targeting at TGF-β2

Overexpression of Mechanical Sensitive Mir-337-3p Alleviates Ectopic Ossification in Rat Tendinopathy Model Via Targeting IRS1 and Nox4 of Tendon Derived Stem Cells

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

Inhibition of Integrin α v β 6 Activation of TGF‐ β Attenuates Tendinopathy

Tissue-engineered mesenchymal stem cell constructs alleviate tendinopathy by suppressing vascularization

Analysis of the lncRNA-Associated Competing Endogenous RNA (ceRNA) Network for Tendinopathy

Identification of Differentially Expressed Genes and Small Molecule Drugs for the Treatment of Tendinopathy Using Microarray Analysis

TGF‐β/SMAD signaling inhibits intermittent cyclic mechanical tension‐induced degeneration of endplate chondrocytes by regulating the miR‐455‐5p/RUNX2 axis

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

MiR124 Suppresses Collagen Formation of Human Tendon Derived Stem Cells Through Targeting Egr1.

The Angiogenic Effect of Microrna-21 Targeting Timp3 Through the Regulation of Mmp2 and Mmp9

Integrative Single-Cell RNA and ATAC Sequencing Reveals That the FOXO1-PRDX2-TNF Axis Regulates Tendinopathy.

Mohawk impedes angiofibrosis by preventing the differentiation of tendon stem/progenitor cells into myofibroblasts

COX2 Enhances Neovascularization of Inflammatory Tenocytes Through the HIF-1α/VEGFA/PDGFB Pathway.

Hypoxia inducible factor-1α mediates the mechanism of the Hedgehog pathway in tendinopathy repair by Asperosaponin VI

Effectiveness of Microrna in Down-Regulation of Tgf-Beta Gene Expression in Digital Flexor Tendons of Chickens: in Vitro and in Vivo Study

Aspirin Promotes Tenogenic Differentiation of Tendon Stem Cells and Facilitates Tendinopathy Healing Through Regulating the GDF7/Smad1/5 Signaling Pathway.

MicroRNA-146a gene transfer ameliorates senescence and senescence-associated secretory phenotypes in tendinopathic tenocytes

CTHRC1 Attenuates Tendinopathy Via Enhancing EGFR/MAPK Signaling Pathway

Role of VEGF, Nitric Oxide, and Sympathetic Neurotransmitters in the Pathogenesis of Tendinopathy: A Review of the Current Evidences